| Product Code: ETC9968526 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Intravenous (IV) Therapy and Vein Access Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Intravenous (IV) Therapy and Vein Access Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Intravenous (IV) Therapy and Vein Access Market - Industry Life Cycle |
3.4 United States (US) Intravenous (IV) Therapy and Vein Access Market - Porter's Five Forces |
3.5 United States (US) Intravenous (IV) Therapy and Vein Access Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 United States (US) Intravenous (IV) Therapy and Vein Access Market Revenues & Volume Share, By Medical Application, 2021 & 2031F |
3.7 United States (US) Intravenous (IV) Therapy and Vein Access Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 United States (US) Intravenous (IV) Therapy and Vein Access Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases requiring IV therapy |
4.2.2 Technological advancements in vein access devices |
4.2.3 Growing geriatric population in the United States |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval process for IV therapy products |
4.3.2 Risk of infections associated with IV therapy |
4.3.3 Limited reimbursement policies for IV therapy services |
5 United States (US) Intravenous (IV) Therapy and Vein Access Market Trends |
6 United States (US) Intravenous (IV) Therapy and Vein Access Market, By Types |
6.1 United States (US) Intravenous (IV) Therapy and Vein Access Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Intravenous (IV) Therapy and Vein Access Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 United States (US) Intravenous (IV) Therapy and Vein Access Market Revenues & Volume, By Implantable Ports, 2021- 2031F |
6.1.4 United States (US) Intravenous (IV) Therapy and Vein Access Market Revenues & Volume, By Intravenous Catheters, 2021- 2031F |
6.1.5 United States (US) Intravenous (IV) Therapy and Vein Access Market Revenues & Volume, By Hypodermic Needles, 2021- 2031F |
6.1.6 United States (US) Intravenous (IV) Therapy and Vein Access Market Revenues & Volume, By Infusion Pumps, 2021- 2031F |
6.1.7 United States (US) Intravenous (IV) Therapy and Vein Access Market Revenues & Volume, By Other, 2021- 2031F |
6.2 United States (US) Intravenous (IV) Therapy and Vein Access Market, By Medical Application |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Intravenous (IV) Therapy and Vein Access Market Revenues & Volume, By Nutrition And Buffer Solution, 2021- 2031F |
6.2.3 United States (US) Intravenous (IV) Therapy and Vein Access Market Revenues & Volume, By Volume Expander, 2021- 2031F |
6.2.4 United States (US) Intravenous (IV) Therapy and Vein Access Market Revenues & Volume, By Medication Administration, 2021- 2031F |
6.2.5 United States (US) Intravenous (IV) Therapy and Vein Access Market Revenues & Volume, By Blood Based Products, 2021- 2031F |
6.3 United States (US) Intravenous (IV) Therapy and Vein Access Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Intravenous (IV) Therapy and Vein Access Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 United States (US) Intravenous (IV) Therapy and Vein Access Market Revenues & Volume, By Ambulatory Surgical Center, 2021- 2031F |
6.3.4 United States (US) Intravenous (IV) Therapy and Vein Access Market Revenues & Volume, By Clinics, 2021- 2031F |
7 United States (US) Intravenous (IV) Therapy and Vein Access Market Import-Export Trade Statistics |
7.1 United States (US) Intravenous (IV) Therapy and Vein Access Market Export to Major Countries |
7.2 United States (US) Intravenous (IV) Therapy and Vein Access Market Imports from Major Countries |
8 United States (US) Intravenous (IV) Therapy and Vein Access Market Key Performance Indicators |
8.1 Average length of hospital stay for patients receiving IV therapy |
8.2 Number of healthcare facilities offering specialized IV therapy services |
8.3 Rate of adoption of innovative vein access technologies |
8.4 Patient satisfaction scores related to IV therapy services |
8.5 Percentage of healthcare professionals trained in IV therapy techniques |
9 United States (US) Intravenous (IV) Therapy and Vein Access Market - Opportunity Assessment |
9.1 United States (US) Intravenous (IV) Therapy and Vein Access Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 United States (US) Intravenous (IV) Therapy and Vein Access Market Opportunity Assessment, By Medical Application, 2021 & 2031F |
9.3 United States (US) Intravenous (IV) Therapy and Vein Access Market Opportunity Assessment, By End User, 2021 & 2031F |
10 United States (US) Intravenous (IV) Therapy and Vein Access Market - Competitive Landscape |
10.1 United States (US) Intravenous (IV) Therapy and Vein Access Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Intravenous (IV) Therapy and Vein Access Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here